Summary
Amrinone has been shown to produce haemodynamic benefits in digitalis-treated patients. Since amrinone is a positive inotropic agent on isolated heart muscle, these benefits may mean that amrinone increases the maximal ouabain-induced increase in force of contraction, without causing toxicity. We have therefore measured, in cat right ventricular papillary muscles, the inotropic effects of ouabain, amrinone alone and amrinone with a maximally effective, non-toxic ouabain concentration (2×10−7 M). Ouabain is much more potent than amrinone (EC50-values: ouabain, 8×10−8 M, amrinone, 1–2.8×10−3 M). The highest amrinone concentration used (6×10−3 M) produced a significantly lower increase in force of contraction than ouabain (2×10−7 M) in the same muscles. After ouabain (2×10−7 M) produced a stable effect, no further increase in force of contraction was observed with any amrinone concentration. Sustained arrhythmias were observed in five of six muscles at 3×10−3 M amrinone with ouabain (2×10−7 M), but in only one of these muscles with amrinone 3×10−3 M alone. Since the positive inotropic effects of amrinone are not additive with those from a maximally effective ouabain concentration, the haemodynamic benefits seen in patients are probably due to non-cardiac effects of amrinone such as vasodilatation.
Similar content being viewed by others
References
Adams HR, Rhody J, Sutko JL (1982) Amrinone activates K+-depolarized atrial and ventricular myocardium of guinea pigs. Circ Res 51:662–665
Alousi AA, Farah AE, Lesher GY, Opalka CJ Jr (1979) Cardiotonic activity of amrinone — Win 40680 (5-amino-3.4′-bipyridin-(1H)-one). Circ Res 45:666–677
Bayliss J, Norell M, Canepa-Anson R, Reuben SR, Poole-Wilson PA, Sutton GC (1983) Acute haemodynamic comparison of amrinone and pirbuterol in chronic heart failure. Additional effects of isosorbide dinitrate. Br Heart J 49:214–221
Benotti JR, Grossman W, Braunwald E, Davolos DD, Alousi AA (1978) Hemodynamic assessment of amrinone. A new inotropic agent. N Engl J Med 299:1373–1377
Binah O, Legato MJ, Danilo P Jr, Rosen MR (1983) Developmental changes in the cardiac effects of amrinone in the dog. Circ Res 52:747–752
Brown L, Erdmann E (1984) Comparison of the affinity of human, beef and cat heart (Na++K+)-ATPase for different digitalis derivatives. Arzneim Forsch, in press
Canepa-Anson R, Dawson JR, Frankl WS, Kuan P, Sutton GC, Reuben S, Poole-Wilson PA (1982) Beta2 adrenoceptor agonists. Pharmacology, metabolic effects and arrhythmias. Eur Heart J 3(supp D):129–134
Conrad KA, Prosnitz EH (1981) Cardiovascular effects of theophylline. Partial attenuation by beta blockade. Eur J Clin Pharmacol 21:109–114
Endoh M, Yamashita S, Taira N (1982) Positive inotropic effect of amrinone in relation to cyclic nucleotide metabolism in the canine ventricular muscle. J Pharmacol Exp Ther 221:775–783
Gaide MS, Fitterman WS, Wiggins JR, Myerburg RJ, Cameron JS, Bassett AL (1983) Amrinone relaxes potassium-induced contracture of failing right ventricular muscle of cats. J Cardiovasc Pharmacol 5:335–340
Gilman AG, Goodman LS, Gilman A (1980) The pharmacological basis of therapeutics. 6th edition. Macmillan, New York, pp 729–760
Honerjäger P, Schäfer-Korting M, Reiter M (1981) Involvement of cyclic AMP in the direct inotropic action of amrinone. Biochemical and functional evidence. Naunyn-Schmiedeberg's Arch Pharmacol 318:112–120
LeJemtel TH, Keung E, Ribner HS, Davis R, Wexler J, Blaufox MD, Sonnenblick EH (1980) Sustained beneficial effects of oral amrinone on cardiac and renal function in patients with severe congestive heart failure. Am J Cardiol 45:123–129
LeJemtel TH, Keung E, Sonnenblick EH, Ribner HS, Matsumoto M, Davis R, Schwartz W, Alousi AA, Davolos D (1979) Amrinone: a new non-glycosidic, non-adrenergic cardiotonic agent effective in the treatment of intractable myocardial failure in man. Circulation 59:1098–1104
Kariya T, Wille LJ, Dage RC (1982) Biochemical studies on the mechanism of cardiotonic activity of MDL 17,043. J Cardiovasc Pharmacol 4:509–514
Millard RW, Dubé G, Grupp G, Grupp I, Alousi A, Schwartz A (1980) Direct vasodilator and positive inotropic actions of amrinone. J Mol Cell Cardiol 12:647–652
Miller RR, Vismara LA, Williams DO, Amsterdam EA, Mason DT (1976) Pharmacological mechanisms for left ventricular unloading in clinical congestive heart failure. Differential effects of nitroprusside, phentolamine and nitroglycerin on cardiac function and peripheral circulation. Circ Res 39:127–133
Ogilvie RI, Fernandez PG, Winsberg F (1977) Cardiovascular response to increasing theophylline concentrations. Eur J Clin Pharmacol 12:409–414
Onuaguluchi G, Tanz RD (1981) Cardiac effects of amrinone on rabbit papillary muscle and guinea pig Langendorff heart preparations. J Cardiovasc Pharmacol 3:1342–1355
Robinson PJ, Lvoff R, Chong B, Barrett PA (1981) Amrinone — a new inotropic agent in chronic resistant congestive cardiac failure. Aust NZ J Med 11:666–668
Siegel LA, Keung E, Siskind SJ, Forman R, Feinberg H, Strom J, Efstathakis D, Sonnenblick EH, LeJemtel TH (1981) Beneficial effects of amrinone-hydralazine combination on resting hemodynamics and exercise capacity in patients with severe congestive heart failure. Circulation 63:838–844
Ward A, Brogden RN, Heel RC, Speight TM, Avery GS (1983) Amrinone. A preliminary review of its pharmacological properties and therapeutic use. Drugs 26:468–502
Wilmshurst PT, Thompson DS, Jenkins BS, Coltart DJ, Webb-Peploe MM (1982) Effect of intravenous amrinone on resting haemodynamic function in patients with congestive heart failure. Br Heart J 48:93
Wilmshurst PT, Thompson DS, Miles CM, Juul SM, Jenkins BS, Coltart DJ, Webb-Peploe MM (1983) Comparison of effects of amrinone and nitroprusside in heart failure. Circulation 68 (supp III):127
Wynne J, Malacoff RF, Benotti JR, Curfman GD, Grossman W, Holman BL, Smith TW, Braunwald E (1980) Oral amrinone in refractory congestive heart failure. Am J Cardiol 45:1245–1249
Author information
Authors and Affiliations
Additional information
Supported by the DFG (Er 65/4-3)
Rights and permissions
About this article
Cite this article
Brown, L., Erdmann, E. Non-additive positive inotropic effects of amrinone and ouabain on cat papillary muscles. Klin Wochenschr 62, 390–393 (1984). https://doi.org/10.1007/BF01742294
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01742294